Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Merida Biosciences is a biotechnology company developing a new class of precision therapeutics to selectively and durably eliminate pathogenic antibodies that drive disease. Focused on treating autoimmune and allergic conditions at their root cause, Merida is advancing a robust pipeline of targeted therapies. Its lead program aims to rapidly clear the autoantibodies responsible for Graves' disease.

List your booth number for exhibitions, ask us